Molar pregnancy, also known as gestational trophoblastic disease, is a condition characterized by abnormal growth of trophoblastic tissue, which normally develops into the placenta during pregnancy. It can manifest as complete or partial moles, with complete moles involving the absence of normal embryonic tissue and partial moles containing both abnormal trophoblastic tissue and some fetal formations. Other abnormal products of conception refer to any non-viable tissue formed during an abnormal pregnancy that does not develop normally, potentially resulting in complications such as persistent gestational trophoblastic disease or invasive mole.

Although molar pregnancies can occur in any pregnancy, certain groups, particularly women over 35 years old or those with previous molar pregnancies, are at increased risk. Additionally, women from Asian descent are statistically more likely to experience this condition. Other risks include the potential for persistent gestational trophoblastic disease, which can lead to further complications requiring careful monitoring and treatment.

Common symptoms of a molar pregnancy include vaginal bleeding that may be bright red or brown, unusual pelvic pressure or pain, and the presence of a uterine size that is larger than expected for the gestational age. In some cases, hyperemesis gravidarum (severe nausea and vomiting) and preeclampsia symptoms may appear earlier than in normal pregnancies. Additionally, physical signs may include the presence of cysts in the ovaries, found during routine ultrasounds.

The exact causes of molar pregnancy are not fully understood, but risk factors include advanced maternal age, history of molar pregnancies, and certain dietary deficiencies, such as low protein and folic acid intake. Chromosomal abnormalities play a significant role, with complete moles typically arising from fertilization of an egg with no genetic material or fertilization of an empty egg by two sperms. These chromosomal abnormalities lead to the overgrowth of trophoblastic tissue, disrupting normal pregnancy development.

Molar pregnancy is typically diagnosed through a combination of pelvic examinations, ultrasounds, and blood tests measuring human chorionic gonadotropin (hCG) levels. Ultrasound findings may reveal characteristic 'snowstorm' patterns of tissue in complete moles or abnormal fetal development in partial moles. Elevated hCG levels beyond expected thresholds for gestational age serve as a key indicator for further evaluation and potential diagnosis.

The primary treatment for a molar pregnancy involves the removal of the abnormal tissue through a procedure called dilation and curettage (D&C). After the procedure, patients must be closely monitored through regular hCG level checks to ensure complete removal and to detect any potential complications. In cases where the mole persists or becomes invasive, further treatment options may include chemotherapy or other medical interventions.

Preventative measures for molar pregnancy primarily include maintaining a healthy lifestyle and nutrition, particularly if there is a history of previous molar pregnancy or other risk factors. Women who have previously experienced a molar pregnancy are often advised to wait at least 6-12 months before attempting to conceive again, allowing for thorough monitoring and follow-up. Genetic counseling may also be beneficial for those with family histories of gestational trophoblastic disease.